Vaccine study finds jabs effective
China’s Sinovac Covid-19 vaccine and the formula by AstraZeneca have both been found to boost antibody responses in almost all vaccine recipients.
This was the outcome of a study into a vaccination programme run by the Center of Excellence in Clinical Virology of the Faculty of Medicine at Chulalongkorn University.
Up to 97.26% of the people receiving the AstraZeneca vaccine were found to have developed immune responses in tests conducted four weeks after their first shot, said Prof Sirirerk Songwilai, permanent secretary of Higher Education Science Research and Innovation Ministry.
Bangkok Post Reporter